Corporate Banner
Satellite Banner
Stem Cells, Cellular Therapy & Biobanking
Scientific Community
Become a Member | Sign in
Home>News>This Article

Geron Corporation Appoints Karin Eastham to its Board of Directors

Published: Monday, March 30, 2009
Last Updated: Monday, March 30, 2009
Bookmark and Share
Geron Corporation has announced the appointment of Karin Eastham to its board of directors. Ms. Eastham will also serve as chair of the company’s audit committee.

Karin Eastham currently serves on the boards of directors for several life science companies, including Amylin Pharmaceuticals, Inc., Illumina, Inc. and Genoptix, Inc. She is also on the board of the Corporate Directors Forum, which focuses on promoting best practices in corporate governance. Past directorships include SGX Pharmaceuticals, Inc., Tercica, Inc., Molecular Probes, Inc. and Salmedix, Inc. Ms. Eastham most recently served as executive vice president and chief operating officer and a member of the board of trustees of the Burnham Institute for Medical Research. She previously served as senior vice president of finance, chief financial officer, and secretary of Diversa Corporation and held senior management positions with CombiChem, Inc., Cytel Corporation and Boehringer Mannheim Diagnostics. Ms. Eastham earned her B.S. in Accounting and M.B.A in Finance from Indiana University and is a certified public accountant and a certified director.

“I am pleased to welcome Ms. Eastham to our board of directors,” said Thomas B. Okarma, Ph.D., M.D., Geron’s president and chief executive officer. “Karin brings to the board over 30 years of experience in the financial and operations management of life science companies and we look forward to her advice and counsel.”

Ms. Eastham will join Geron’s existing board members: board chair Alexander E. Barkas, Ph.D., Edward V. Fritzky, Charles J. Homcy, M.D., Thomas D. Kiley, Patrick J. Zenner and Geron’s president and CEO, Thomas B. Okarma.

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Geron Receives FDA Clearance to Begin World's First Human Clinical Trial of Embryonic Stem Cell-Based Therapy
Geron Corporation announced that the U.S. Food and Drug Administration (FDA) has granted clearance of the company’s Investigational New Drug (IND) application for the clinical trial of GRNOPC1 in patients with acute spinal cord injury.
Friday, January 23, 2009
Geron Issues Statement regarding European Patent Office Decision in WARF Patent Appeal
Geron Corporation announced that the Enlarged Board of Appeals of the European Patent Office (EPO) has issued a decision in case G0002/06, which was an appeal by the Wisconsin Alumni Research Foundation (WARF) against the rejection of claims in WARF’s European Patent Application No. 96903521.1.
Friday, November 28, 2008
Geron Scientists and Collaborators Demonstrate Activity of Pancreatic Islet-like Cells Derived from Human Embryonic Stem Cells in Diabetes
Survival of Diabetic Mice Improved After Transplantation of hESC-derived ILCs.
Tuesday, October 28, 2008
Scientific News
How a Genetic Locus Protects Adult Blood-Forming Stem Cells
Mammalian imprinted Gtl2 protects adult hematopoietic stem cells by restricting metabolic activity in the cells' mitochondria.
Fat Cells Originating from Bone Marrow Found in Humans
Cells could contribute to diabetes, heart disease.
Ancient Viral Molecules Essential for Human Development
Genetic material from ancient viral infections is critical to human development, according to researchers at the Stanford University School of Medicine.
CRI Identifies Emergency Blood-formation Response
Researchers report that when tissue damage occurs, an emergency blood-formation system activates.
New Way to Force Stem Cells to Become Bone Cells
Potential therapies based on this discovery could help people heal bone injuries or set hardware, such as replacement knees and hips.
Dead Bacteria to Kill Colorectal Cancer
Scientists from Nanyang Technological University (NTU Singapore) have successfully used dead bacteria to kill colorectal cancer cells.
Promise of Newborn Stem Cells to Revolutionize Clinical Practice
In this article Shweta Sharma, PhD, discusses the potential of an Umbilical Cord Blood bank as an untapped source of samples for research and clinical trials.
The Life Story of Stem Cells
A model analyses the development of stem cell numbers in the human body.
Novel Stem Cell Line Avoids Risk of Introducing Transplanted Tumors
Progenitor cells might eventually be used to repair or rebuild damaged or destroyed organs.
Advancing Genome Editing of Blood Stem Cells
Genome editing techniques for blood stem cells just got better, thanks to a team of researchers at USC and Sangamo BioSciences.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos